Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1997-11-18
|
pubmed:abstractText |
Historically, the application of chemotherapy in patients with squamous cell head and neck cancer had been limited to the palliative setting; however, the role of chemotherapy in the definitive management of these tumors has undergone great evolution during the last 5 to 10 years. Available randomized data currently support a role for chemotherapy as part of combined modality, curative treatment strategies in the management of patients with unresectable disease, advanced nasopharynx cancer, and as part of a larynx preservation approach in patients with advanced larynx or hypopharynx cancer requiring total laryngectomy. Chemoprevention as a strategy to prevent second primary tumors also shows great promise.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1055-3207
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
749-68
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9309092-Antineoplastic Agents,
pubmed-meshheading:9309092-Carcinoma, Squamous Cell,
pubmed-meshheading:9309092-Chemoprevention,
pubmed-meshheading:9309092-Combined Modality Therapy,
pubmed-meshheading:9309092-Head and Neck Neoplasms,
pubmed-meshheading:9309092-Humans,
pubmed-meshheading:9309092-Hypopharyngeal Neoplasms,
pubmed-meshheading:9309092-Laryngeal Neoplasms,
pubmed-meshheading:9309092-Laryngectomy,
pubmed-meshheading:9309092-Nasopharyngeal Neoplasms,
pubmed-meshheading:9309092-Neoplasms, Second Primary,
pubmed-meshheading:9309092-Palliative Care,
pubmed-meshheading:9309092-Randomized Controlled Trials as Topic,
pubmed-meshheading:9309092-Remission Induction,
pubmed-meshheading:9309092-Survival Rate
|
pubmed:year |
1997
|
pubmed:articleTitle |
The role of chemotherapy in the curative treatment of head and neck cancer.
|
pubmed:affiliation |
Department of Medicine, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
|
pubmed:publicationType |
Journal Article,
Review
|